Hinge Health, Inc. (HNGE) Stock Analysis
Recovery setup
Healthcare · Health Information Services
Sell if holding. At $45.01, A.R:R 1.0:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 2.1): -1.5; Earnings in 5 days (event risk).
Hinge Health provides AI-powered digital MSK care for self-insured employers and health plans, covering 22M+ employer lives and 3M+ fully-insured and Medicare Advantage lives. Revenue is subscription/engagement-based, contracted primarily through 60+ health plan and PBM partners.
Sell if holding. At $45.01, A.R:R 1.0:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 2.1): -1.5; Earnings in 5 days (event risk). Chart setup: Death cross but MACD improving, RSI 83. Score 5.8/10, moderate confidence.
Passes 4/8 gates (clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and death cross (50MA < 200MA) and earnings proximity 5d<=7d. Suitability: aggressive.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMCustomerHealth Care Service Corporation18%10-K Item 1A: 'client contracts through (i) Health Care Service Corporation ("HCSC") accounted for 17.5% and 17.1% of our revenue, respectively'
- MEDIUMCustomerElevance Health14%10-K Item 1A: '(ii) Elevance Health, Inc., formerly known as Anthem, Inc. ("Elevance"), accounted for 13.7% and 14.0% of our revenue, respectively'
- LOWCustomerAetna Life Insurance Company11%10-K Item 1A: '(iii) Aetna Life Insurance Company ("Aetna") accounted for 10.5% and 11.6% of our revenue, respectively'
Material Events(8-K, last 90d)
- 2026-03-17Item 5.02LOWTyler Sloat appointed Class I director and Compensation Committee Chair effective March 16, 2026; also appointed to Audit Committee. Sloat is COO/CFO at Freshworks Inc. No departures noted.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers·1 ceiling hit
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. At $45.01, A.R:R 1.0:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 2.1): -1.5; Earnings in 5 days (event risk). Chart setup: Death cross but MACD improving, RSI 83. Prior stop was $41.85. Score 5.8/10, moderate confidence.
Take-profit target: $51.78 (+15.1% upside). Prior stop was $41.85. Stop-loss: $41.85.
Leverage penalty (D/E 2.1): -1.5; Earnings in 5 days (event risk); Overbought (RSI 83).
Hinge Health, Inc. trades at a P/E of N/A (forward 19.0). TrendMatrix value score: 7.4/10. Verdict: Sell.
23 analysts cover HNGE with a consensus score of 4.1/5. Average price target: $58.
What does Hinge Health, Inc. do?Hinge Health provides AI-powered digital MSK care for self-insured employers and health plans, covering 22M+ employer...
Hinge Health provides AI-powered digital MSK care for self-insured employers and health plans, covering 22M+ employer lives and 3M+ fully-insured and Medicare Advantage lives. Revenue is subscription/engagement-based, contracted primarily through 60+ health plan and PBM partners.